United States Nuclear Medicine/Radiopharmaceuticals Market Report 2017

United States Nuclear Medicine/Radiopharmaceuticals Market Report 2017

1 Nuclear Medicine/Radiopharmaceuticals Overview

1.1 Product Overview and Scope of Nuclear Medicine/Radiopharmaceuticals

1.2 Classification of Nuclear Medicine/Radiopharmaceuticals by Product Category

1.2.1 United States Nuclear Medicine/Radiopharmaceuticals Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Nuclear Medicine/Radiopharmaceuticals Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Diagnostic

1.2.4 Therapeutic

1.3 United States Nuclear Medicine/Radiopharmaceuticals Market by Application/End Users

1.3.1 United States Nuclear Medicine/Radiopharmaceuticals Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Oncology

1.3.3 Thyroid

1.3.4 Cardiology

1.3.5 Other

1.4 United States Nuclear Medicine/Radiopharmaceuticals Market by Region

1.4.1 United States Nuclear Medicine/Radiopharmaceuticals Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Nuclear Medicine/Radiopharmaceuticals Status and Prospect (2012-2022)

1.4.3 Southwest Nuclear Medicine/Radiopharmaceuticals Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Nuclear Medicine/Radiopharmaceuticals Status and Prospect (2012-2022)

1.4.5 New England Nuclear Medicine/Radiopharmaceuticals Status and Prospect (2012-2022)

1.4.6 The South Nuclear Medicine/Radiopharmaceuticals Status and Prospect (2012-2022)

1.4.7 The Midwest Nuclear Medicine/Radiopharmaceuticals Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Nuclear Medicine/Radiopharmaceuticals (2012-2022)

1.5.1 United States Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2012-2022)

1.5.2 United States Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2012-2022)

2 United States Nuclear Medicine/Radiopharmaceuticals Market Competition by Players/Suppliers

2.1 United States Nuclear Medicine/Radiopharmaceuticals Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Nuclear Medicine/Radiopharmaceuticals Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Nuclear Medicine/Radiopharmaceuticals Average Price by Players/Suppliers (2012-2017)

2.4 United States Nuclear Medicine/Radiopharmaceuticals Market Competitive Situation and Trends

2.4.1 United States Nuclear Medicine/Radiopharmaceuticals Market Concentration Rate

2.4.2 United States Nuclear Medicine/Radiopharmaceuticals Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Nuclear Medicine/Radiopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Type

3 United States Nuclear Medicine/Radiopharmaceuticals Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Region (2012-2017)

3.2 United States Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Region (2012-2017)

3.3 United States Nuclear Medicine/Radiopharmaceuticals Price by Region (2012-2017)

4 United States Nuclear Medicine/Radiopharmaceuticals Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Type (2012-2017)

4.3 United States Nuclear Medicine/Radiopharmaceuticals Price by Type (2012-2017)

4.4 United States Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate by Type (2012-2017)

5 United States Nuclear Medicine/Radiopharmaceuticals Sales (Volume) by Application (2012-2017)

5.1 United States Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Application (2012-2017)

5.2 United States Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Nuclear Medicine/Radiopharmaceuticals Players/Suppliers Profiles and Sales Data

6.1 GE Healthcare

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 GE Healthcare Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Bracco Imaging

6.2.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Bracco Imaging Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Mallinckrodt

6.3.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Mallinckrodt Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Lantheus Medical Imaging

6.4.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Bayer

6.5.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Bayer Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Triad Isotopes

6.6.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Triad Isotopes Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Nordion

6.7.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Nordion Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Jubilant Pharma

6.8.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Jubilant Pharma Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Eli Lilly

6.9.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Eli Lilly Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Siemens

6.10.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Siemens Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 China Isotope & Radiation

6.12 Dongcheng

7 Nuclear Medicine/Radiopharmaceuticals Manufacturing Cost Analysis

7.1 Nuclear Medicine/Radiopharmaceuticals Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceuticals

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Nuclear Medicine/Radiopharmaceuticals Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Nuclear Medicine/Radiopharmaceuticals Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Nuclear Medicine/Radiopharmaceuticals Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Nuclear Medicine/Radiopharmaceuticals Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Nuclear Medicine/Radiopharmaceuticals Sales Volume Forecast by Type (2017-2022)

11.3 United States Nuclear Medicine/Radiopharmaceuticals Sales Volume Forecast by Application (2017-2022)

11.4 United States Nuclear Medicine/Radiopharmaceuticals Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Nuclear Medicine/Radiopharmaceuticals

Figure United States Nuclear Medicine/Radiopharmaceuticals Market Size (K Units) by Type (2012-2022)

Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Volume Market Share by Type (Product Category) in 2016

Figure Diagnostic Product Picture

Figure Therapeutic Product Picture

Figure United States Nuclear Medicine/Radiopharmaceuticals Market Size (K Units) by Application (2012-2022)

Figure United States Sales Market Share of Nuclear Medicine/Radiopharmaceuticals by Application in 2016

Figure Oncology Examples

Figure Thyroid Examples

Figure Cardiology Examples

Figure Other Examples

Figure United States Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Region (2012-2022)

Figure The West Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Nuclear Medicine/Radiopharmaceuticals Sales (K Units) and Growth Rate (2012-2022)

Figure United States Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Nuclear Medicine/Radiopharmaceuticals Market Major Players Product Sales Volume (K Units) (2012-2017)

Table United States Nuclear Medicine/Radiopharmaceuticals Sales (K Units) of Key Players/Suppliers (2012-2017)

Table United States Nuclear Medicine/Radiopharmaceuticals Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Nuclear Medicine/Radiopharmaceuticals Sales Share by Players/Suppliers

Figure 2017 United States Nuclear Medicine/Radiopharmaceuticals Sales Share by Players/Suppliers

Figure United States Nuclear Medicine/Radiopharmaceuticals Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Nuclear Medicine/Radiopharmaceuticals Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Nuclear Medicine/Radiopharmaceuticals Revenue Share by Players/Suppliers

Figure 2017 United States Nuclear Medicine/Radiopharmaceuticals Revenue Share by Players/Suppliers

Table United States Market Nuclear Medicine/Radiopharmaceuticals Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)

Figure United States Market Nuclear Medicine/Radiopharmaceuticals Average Price (USD/Unit) of Key Players/Suppliers in 2016

Figure United States Nuclear Medicine/Radiopharmaceuticals Market Share of Top 3 Players/Suppliers

Figure United States Nuclear Medicine/Radiopharmaceuticals Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Nuclear Medicine/Radiopharmaceuticals Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Nuclear Medicine/Radiopharmaceuticals Product Category

Table United States Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Region (2012-2017)

Table United States Nuclear Medicine/Radiopharmaceuticals Sales Share by Region (2012-2017)

Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Share by Region (2012-2017)

Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region in 2016

Table United States Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Nuclear Medicine/Radiopharmaceuticals Revenue Share by Region (2012-2017)

Figure United States Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region (2012-2017)

Figure United States Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region in 2016

Table United States Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) by Region (2012-2017)

Table United States Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Type (2012-2017)

Table United States Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2012-2017)

Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Share by Type (2012-2017)

Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type in 2016

Table United States Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Nuclear Medicine/Radiopharmaceuticals Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Nuclear Medicine/Radiopharmaceuticals by Type (2012-2017)

Figure Revenue Market Share of Nuclear Medicine/Radiopharmaceuticals by Type in 2016

Table United States Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) by Types (2012-2017)

Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate by Type (2012-2017)

Table United States Nuclear Medicine/Radiopharmaceuticals Sales (K Units) by Application (2012-2017)

Table United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2012-2017)

Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2012-2017)

Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2016

Table United States Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate by Application (2012-2017)

Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate by Application (2012-2017)

Table GE Healthcare Basic Information List

Table GE Healthcare Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure GE Healthcare Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2012-2017)

Figure GE Healthcare Nuclear Medicine/Radiopharmaceuticals Sales Market Share in United States (2012-2017)

Figure GE Healthcare Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in United States (2012-2017)

Table Bracco Imaging Basic Information List

Table Bracco Imaging Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Bracco Imaging Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2012-2017)

Figure Bracco Imaging Nuclear Medicine/Radiopharmaceuticals Sales Market Share in United States (2012-2017)

Figure Bracco Imaging Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in United States (2012-2017)

Table Mallinckrodt Basic Information List

Table Mallinckrodt Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Mallinckrodt Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2012-2017)

Figure Mallinckrodt Nuclear Medicine/Radiopharmaceuticals Sales Market Share in United States (2012-2017)

Figure Mallinckrodt Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in United States (2012-2017)

Table Lantheus Medical Imaging Basic Information List

Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2012-2017)

Figure Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceuticals Sales Market Share in United States (2012-2017)

Figure Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in United States (2012-2017)

Table Bayer Basic Information List

Table Bayer Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Bayer Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2012-2017)

Figure Bayer Nuclear Medicine/Radiopharmaceuticals Sales Market Share in United States (2012-2017)

Figure Bayer Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in United States (2012-2017)

Table Triad Isotopes Basic Information List

Table Triad Isotopes Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Triad Isotopes Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2012-2017)

Figure Triad Isotopes Nuclear Medicine/Radiopharmaceuticals Sales Market Share in United States (2012-2017)

Figure Triad Isotopes Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in United States (2012-2017)

Table Nordion Basic Information List

Table Nordion Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Nordion Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2012-2017)

Figure Nordion Nuclear Medicine/Radiopharmaceuticals Sales Market Share in United States (2012-2017)

Figure Nordion Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in United States (2012-2017)

Table Jubilant Pharma Basic Information List

Table Jubilant Pharma Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Jubilant Pharma Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2012-2017)

Figure Jubilant Pharma Nuclear Medicine/Radiopharmaceuticals Sales Market Share in United States (2012-2017)

Figure Jubilant Pharma Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in United States (2012-2017)

Table Eli Lilly Basic Information List

Table Eli Lilly Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Eli Lilly Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2012-2017)

Figure Eli Lilly Nuclear Medicine/Radiopharmaceuticals Sales Market Share in United States (2012-2017)

Figure Eli Lilly Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in United States (2012-2017)

Table Siemens Basic Information List

Table Siemens Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Siemens Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2012-2017)

Figure Siemens Nuclear Medicine/Radiopharmaceuticals Sales Market Share in United States (2012-2017)

Figure Siemens Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in United States (2012-2017)

Table China Isotope & Radiation Basic Information List

Table Dongcheng Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Nuclear Medicine/Radiopharmaceuticals

Figure Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceuticals

Figure Nuclear Medicine/Radiopharmaceuticals Industrial Chain Analysis

Table Raw Materials Sources of Nuclear Medicine/Radiopharmaceuticals Major Players/Suppliers in 2016

Table Major Buyers of Nuclear Medicine/Radiopharmaceuticals

Table Distributors/Traders List

Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) and Growth Rate Forecast (2017-2022)

Figure United States Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Nuclear Medicine/Radiopharmaceuticals Price (USD/Unit) Trend Forecast (2017-2022)

Table United States Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) Forecast by Type in 2022

Table United States Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) Forecast by Application in 2022

Table United States Nuclear Medicine/Radiopharmaceuticals Sales Volume (K Units) Forecast by Region (2017-2022)

Table United States Nuclear Medicine/Radiopharmaceuticals Sales Volume Share Forecast by Region (2017-2022)

Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Volume Share Forecast by Region (2017-2022)

Figure United States Nuclear Medicine/Radiopharmaceuticals Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources